the first all in Finland developed imaging related to the radio of the drug has advanced to human studies, says the university of Turku.
the Substance used is a positron emission during the ct scan, elipa you on a photo shoot and it is hoped to contribute to inflammatory diseases, for example rheumatoid arthritis and associated diseases, early diagnostics and drug development.
the radio of the drug is developed by Turku university professor Anne Roivainen research team of Turku national PET research center together with the academician, the professor Sirpa Jalkanen with.
the first experiments were made in healthy people.
radio drug development is very similar to drug development. Years of preclinical studies, we have finally progressed to human studies. Of the clinical trial in the first stage of a radio pharmaceutical substance is administered for the first time people. In this case, there is only a few healthy individuals, Roivainen said in the announcement.
Now in the second phase the drug is tested in a small number of patients.
– now we are Looking for research according to rheumatoid arthritis patients, together with TUCH:no reumatologian unit chief Laura Pirilä, and other reumatologien with. According to the wish of ten patients, Roivainen said.
in the Next step find out if you can find a new radio drug for inflammation of the imaging context.
– Inflammation is a significant component of many long-term illnesses, and treatment success in terms of it should be identified in a timely manner. Came studies show the suitability of the new radio drug for inflammation imaging, is multiplied by the Turku university bulletin.
the Research was funded by the Academy of Finland, Southwest Finland hospital district (ERVA-financial), Jane and Aatos Erkko foundation, Sigrid Juséliuksen foundation, Business Finland and the heart research foundation.
Subscribe Yle newsletters!
Get Overeating the best content straight to your inbox!
Proceed to order
